Stefan Mereiter
Impact in
- Immunology top 5%
- Galectins and Cancer Biology
- Immunotherapy and Immune Responses
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research
- Ubiquitin and proteasome pathways
Papers in
-
- Glycosylation and Glycoproteins Research 18
-
- Galectins and Cancer Biology 8
- Co-authors
- Celso A. Reis (21 shared papers)Meritxell Balmaña (9 shared papers)Joana Gomes (8 shared papers)Diana Campos (3 shared papers)Ana Magalhães (8 shared papers)Catarina Gomes (4 shared papers)Joana A. Macedo (3 shared papers)Ângela Fernandes (1 shared paper)
In The Last Decade
Stefan Mereiter
24 papers receiving 1.0k citations
Stefan Mereiter's Hit Papers
Peers
Comparison fields: 5 of 80
- Immunology 433
- Molecular Biology 837
- Biotechnology 81
- Cell Biology 114
- Cancer Research 94
Countries citing papers authored by Stefan Mereiter
This map shows the geographic impact of Stefan Mereiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Mereiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Mereiter more than expected).
Fields of papers citing papers by Stefan Mereiter
This network shows the impact of papers produced by Stefan Mereiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Mereiter. The network helps show where Stefan Mereiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Mereiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading? Hit paper breakdown → | 2019 | 380 |
| 2 | 2018 | 171 | |
| 3 | 2019 | 71 | |
| 4 | 2016 | 50 | |
| 5 | 2015 | 50 | |
| 6 | 2021 | 44 | |
| 7 | 2019 | 35 | |
| 8 | 2017 | 29 | |
| 9 | 2020 | 23 | |
| 10 | 2017 | 22 | |
| 11 | 2017 | 19 | |
| 12 | 2018 | 19 | |
| 13 | 2018 | 18 | |
| 14 | 2020 | 16 | |
| 15 | 2018 | 14 | |
| 16 | 2020 | 11 | |
| 17 | 2016 | 11 | |
| 18 | 2021 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2013 | 6 |
About Stefan Mereiter
Stefan Mereiter is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (18 papers), Galectins and Cancer Biology (8 papers), Cancer Research and Treatments (5 papers), Carbohydrate Chemistry and Synthesis (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cell Adhesion Molecules Research (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Immunology (433 citations), Molecular Biology (837 citations), Biotechnology (81 citations), Cell Biology (114 citations) and Cancer Research (94 citations). Stefan Mereiter has collaborated with scholars based in Portugal, Sweden and Italy. Frequent co-authors include Celso A. Reis, Meritxell Balmaña, Joana Gomes, Diana Campos, Ana Magalhães, Catarina Gomes, Joana A. Macedo, Ângela Fernandes, Salomé S. Pinho and Julio Cesar Madureira de‐Freitas‐Junior. Their work appears in journals such as International Journal of Molecular Sciences, Glycobiology, Scientific Reports, Materials Science and Engineering C and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.